Reuters logo
BRIEF-ProQR Therapeutics spins out Amylon Therapeutics
2017年9月12日 / 中午11点38分 / 14 天前

BRIEF-ProQR Therapeutics spins out Amylon Therapeutics

Sept 12 (Reuters) - ProQR Therapeutics Nv:

* ProQR therapeutics - spun out Amylon Therapeutics, a privately-held company focused on development of therapies for central nervous system disorders

* ProQR Therapeutics Nv - ‍as part of deal, ProQR has granted an exclusive license to Amylon to develop therapeutics for beta amyloid related disorders​

* ProQR Therapeutics - retains majority ownership in amylon, entitled to future milestones, royalties from products developed by Amylon

* ProQR Therapeutics NV - Amylon will be led by Thomas De Vlaam as founding CEO Source text for Eikon: Further company coverage:

我们的标准汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below